I've been in this stock for a year waiting for a move and I've lost 50% of my investment. I'm holding but ready to pull out. They can name Superman to their BOD, and make any announcement they want, but only one thing will bring the stock price up....SALES AND REVENUE!
I feel the pain too. I bought shares at $3 when that was the norm. Today it closed at $1.44. Ouch! But, I expect DRIO to have around $500K revenue based on their soft launch of 3,000 devices. It only takes 1,100 users to make $1M/year. And the ROI is $10/user ($2 user acquisition + $8 for the Dario device). So, I expect 3000 users/1100 = 2.72M/year or $680K/second quarter. But not all users will have started on April 1, so I expect 2nd quarter revenue to be less between $500K-$600K. Now consider the next quarter, without the 3000 soft launch limit, and the expansion into Germany, France, Spain, Netherlands, and Canada, plus expansion into Italy, U.K., New Zealand, and Australia where the soft launch took place. Now we're talking SALES AND REVENUE by the end of the year. Let me know if my numbers seem off.
If you sell - you'll lose %50 of your investment for sure. If you can take a chill pill and let them bring this device to market - both you and I may be surprised. They are so close. You need to have some patience.... GLTA.
BTW - I'm down $5k but still believe they have a winner
Sentiment: Strong Buy
- SeeThruEquity Initiates Research Coverage on LabStyle Innovations with Target Price of $7.24
- LabStyle Innovations Announces Reimbursement Coverage for the use of the Dario™ Personalized Smart Meter in Italy.
I'm in at $2.17 and down $5k. You are in a great position. This is not a hope and a prayer stock unlike biotechs wanting to progress drug trials to stage 3. This is the real deal..... just a matter of time. Hold for the long term and you will be rewarded handsomely. GLTA!
Sentiment: Strong Buy
This will be the stock of the year, trust me. Currently, there is not much interest in the market since lot of people are not aware of the company and also the fact that biotech is been beaten down recently. I really like the way this is playing out, I have been accumulating strongly on the dip. The good news is there are lots of positive feedbacks from the end users and the company is in full gear of execution, only those who are following the company are aware of this news. Once we get FDA clearance, this will hit the wall street and skyrocket at a moment's notice.
Yes, there may be some concerns about dilution or raising funds but in the same time, the company is in the process of generating revenue and the feedbacks from the customers have been quite promising. This, let alone, is the basis of making an investment. Overtime, there will be a fix to the market price and investors will be rewarded handsomely.